METALLOPHILE™ TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • April 8th, 2016 • Viamet Pharmaceuticals Holdings LLC • Pharmaceutical preparations • Delaware
Contract Type FiledApril 8th, 2016 Company Industry JurisdictionThis Metallophile™ Technology License Agreement (“Agreement”), effective as of October 13, 2014 (the “Effective Date”), is entered into by and between VPS-1, Inc., a Delaware corporation with a principal place of business at 4505 Emperor Blvd., Suite 300, Durham, North Carolina 27703 (“Primary”), and Innocrin Pharmaceuticals, Inc. (originally incorporated as Hephestics, Inc. and formerly known as Viamet Pharmaceuticals, Inc.), a Delaware corporation with a principal place of business at 4505 Emperor Blvd., Suite 300, Durham, North Carolina 27703 (“Legacy”). Primary and Legacy may collectively be referred to as the “Parties” (and each, as a “Party”).
METALLOPHILE™ TECHNOLOGY LICENSE AGREEMENTTechnology License Agreement • February 1st, 2016 • Viamet Pharmaceuticals Holdings LLC • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 1st, 2016 Company Industry JurisdictionThis Metallophile™ Technology License Agreement (“Agreement”), effective as of October 13, 2014 (the “Effective Date”), is entered into by and between VPS-1, Inc., a Delaware corporation with a principal place of business at 4505 Emperor Blvd., Suite 300, Durham, North Carolina 27703 (“Primary”), and Innocrin Pharmaceuticals, Inc. (originally incorporated as Hephestics, Inc. and formerly known as Viamet Pharmaceuticals, Inc.), a Delaware corporation with a principal place of business at 4505 Emperor Blvd., Suite 300, Durham, North Carolina 27703 (“Legacy”). Primary and Legacy may collectively be referred to as the “Parties” (and each, as a “Party”).